Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Quest Diagnostics DGX has achieved impressive growth over the past year, with its shares rising 38%. It has outperformed the industry’s 7.7% rise and the S&P 500 composite’s 17.1% gain. Presently ...

This was the stock's third consecutive day of losses.

The stock's rise snapped a three-day losing streak.

Medicare covers many of the tests performed at Quest Diagnostics, as long they’re medically necessary, and the Quest facility you’re using accepts Medicare. Quest Diagnostics is one of the ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Citi downgraded Quest Diagnostics (DGX) to Neutral from Buy with an unchanged price target of $185. The firm believes Quest is well positioned ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Quest Diagnostics Inc. DGX benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight ...

Citigroup cut shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a neutral rating in a report ...